← 返回

英国血液与骨髓移植及细胞治疗学会关于用于治疗血液系统疾病的基因工程先进细胞治疗产品中插入性肿瘤发生的立场声明

英文原题:Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene-engineered advanced cell therapy products for treatment of haematological disorders.

查看英文原题

Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene-engineered advanced cell therapy products for treatment of haematological disorders.

PubMed 2025/11/25(内容时间) Br J Haematol Q2 · IF 3.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

摘要

这条来源本身就没有摘要(PubMed 未提供),不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。

论文信息

作者
Ghorashian S、Sanderson R、Lee J、Black A、O'Reilly MA、Marks DI、Snowden J、Richardson D
第一作者单位
Department of Haematology, Great Ormond Street Hospital for Children, London, UK.United Kingdom
通讯作者单位
Department of Haematology, Imperial College Healthcare NHS Trust, London, UK.United Kingdom
期刊
British journal of haematology2026 Feb
原文标识
PubMed 41287902 · DOI 10.1111/bjh.70247